Showing posts with label Fujifilm Holdings Corporation. Show all posts
Showing posts with label Fujifilm Holdings Corporation. Show all posts

Tuesday 13 November 2018

Endoscopes Market Expected To Trigger A Revenue Increase To 17.19 Billion By 2025:Key Participant Olympus Corporation, Ethicon US


San Francisco, 12 November 2018 , The global endoscopes market size is expected to reach USD 17.19 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.8% during the forecast period. Growing global geriatric population, high prevalence of gastrointestinal diseases, and rising technological advancements are the key factors contributing to market growth. Rising preference for minimally invasive surgeries (MIS) is also positively influencing the growth of the market.
Endoscopy surgeries are performed for diagnosis as well as treatment of gastrointestinal, gynecological, neurological, and cardiovascular diseases. Emergence of minimally invasive alternatives to open surgeries such as laparoscopy, hysteroscopy, and colonoscopy is boosting the demand for endoscopes. Preference of MIS is increasing owing to smaller incision, reduction in postoperative complications & mortality, and lesser trauma. Furthermore, they are economically viable alternatives to open surgeries.
Availability of technologically advanced endoscopes is also providing a significant push to the market. Market players are undertaking R&D initiatives to improve existing products as well as launch new products, which is expected to bolster the growth of the market. For example, VISERA 4K UHD System is a surgical system lunched by Olympus in 2016 with 55-inch primary operative display for enhancing MIS.
In March 2018, Auris Health, Inc. announced FDA approval of its new robotic endoscopy system, Monarch Platform. In June 2017, Olympus launched 3D surgical endoscope designed to be compatible with VISERA ELITE II system. It uses 3D imaging facilitating depth perception that enables precise surgery. Pentax Medical launched Slim Linear Ultrasound Endoscope (EG-3270UK) in the U.S. in August 2017.
Full Research Report On Endoscopes Market Analysis:
www.grandviewresearch.com/industry-analysis/endoscopes-market

Further key findings from the report suggest:
·         Flexible endoscopes emerged as the largest product segment in 2017, accounting for more than half of the market revenue
·         Gastrointestinal endoscopy was the leading revenue contributor in the market, on the basis of applications, in 2017. On the other hand, urology endoscopy is expected to emerge as the fastest growing segment over the forecast period
·         Hospitals was the largest end-use segment in 2018 in terms of revenue. Ambulatory surgery centers are rapidly gaining popularity and the segment is anticipated to register the highest CAGR during the same period
·         North America was the dominant regional market in 2017 due to high healthcare expenditure, favorable reimbursement framework, growing elderly population and disease burden, and heightened adoption of technologically advanced products
·         Asia Pacific is likely to exhibit a lucrative CAGR of 10.6% during the forecast period owing to economic development in emerging countries, improvement in healthcare infrastructure, and increase in awareness about MIS
·         Olympus Corporation; Ethicon US, LLC; Fujifilm Holdings Corporation; Boston Scientific Corporation; Karl Storz GmbH & Co. KG; Stryker; Medtronic; and CONMED Corporation are the leading players in the endoscopes market.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global endoscopes market on the basis of product, applications, end use, and region:
Endoscopes Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Rigid Endoscopes
o    Laparoscopes
o    Arthroscopes
o    Urology endoscopes
o    Cystoscopes
o    Gynecology endoscopes
o    Neuroendoscopes
o    Other rigid endoscopes
·         Flexible Endoscopes
o    Upper gastrointestinal endoscopes
o    Colonoscopes
o    Bronchoscopes
o    Sigmoidoscopes
o    Laryngoscopes
o    Pharyngoscopes
o    Duodenoscopes
o    Nasopharyngoscopes
o    Rhinoscopes
o    Other flexible endoscopes
·         Capsule Endoscopes
·         Disposable Endoscopes
·         Robot Assisted Endoscopes
Endoscopes Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Gastrointestinal (GI) endoscopy
·         Urology endoscopy (cystoscopy)
·         Laparoscopy
·         Obstetrics/gynecology endoscopy
·         Arthroscopy
·         Bronchoscopy
·         Mediastinoscopy
·         Otoscopy
·         Laryngoscopy
·         Other applications
Endoscopes End Use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals
·         Ambulatory surgery centers
·         Other End Uses
Endoscopes Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
o    France
o    Russia
o    Italy
o    Spain
o    Denmark
o    Switzerland
·         Asia Pacific
o    China
o    Japan
o    India
o    Australia
o    New Zealand
o    Thailand
o    Indonesia
o    Malaysia
o    Vietnam
o    Philippines
·         Latin America
o    Brazil
o    Mexico
o    Argentina
·         Middle East & Africa
o    South Africa
o    Saudi Arabia
o    Israel
o    U.A.E.
o    Kuwait

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-endoscopes-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/

Monday 8 October 2018

Breast Imaging Market Expected To Trigger A Revenue Increase To USD 7.3 Billion By 2024:Key Participant Dilon Technologies, Inc., Hologic, Inc.


The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of breast cancer and supportive government initiatives to increase awareness are expected to boost demand in the market.
Supportive government initiatives such UK government campaign’s “Be clear on cancer,” which helped in spreading awareness about the risk factors, preventive measures, and early diagnosis of cancer. This campaign also included free screening programs, which helped in diagnosing around 15,000 cancer patients.
Technological advancements in the imaging sector are expected to boost growth in the market. Companies such as Gamma Medica, Dilon Technologies, and SonoCine are completely dedicated to developing improved technologies in the field of breast imaging. The innovation of complimentary products such as the breast pad designed by GE Healthcare to provide comfort to a woman undergoing screening is expected to catalyze the market growth further.
Full Research Report On Breast Imaging Market Analysis:www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market


Further key findings from the report suggest:
·         The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.
·         North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, promotes the development of personalized medicine, which is anticipated to foster market growth.
·         Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.
·         Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global breast imaging market on the basis of technology and region:
Breast Imaging Technology Outlook (Revenue, USD Million; 2013 - 2024)
·         Ionizing
o    Full-Field Digital Mammography
o    Analog Mammography
o    Positron Emission Mammography
o    Electric Impedance Tomography
o    Cone-Beam Computed Tomography
o    Positron Emission Tomography & Computed Tomography
o    3D Breast Tomosynthesis
o    MBI/BSGI
·         Non Ionizing
o    MRI
o    Thermography
o    Ultrasound
o    Optical Imaging
o    Automated Whole-Breast Ultrasound
Breast Imaging Regional Outlook (Revenue, USD Million; 2013 - 2024)
·         North America
·         Europe
·         Asia Pacific
·         Latin America
·         Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com